Table 4 Regression analyses results for sNfL concentrations at the 7-year follow-up.
Univariate models | Multivariable model 1 | |
|---|---|---|
WMH vol. increase, per cm3 | 0.7 (0.5–0.9)*** | 0.6 (0.4–0.8)*** |
Age, per year | 0.9 (0.7–1.2)*** | 0.8 (0.5–1.1)*** |
Male sex | 1.5 (− 5.5 to 8.5) | − 0.9 (− 7.2 to 5.3) |
Hypertension | 9.3 (2.8 to 15.9)** | 0.4 (− 5.7 to 6.5) |
Hyperlipidemia | 5.5 (− 2.0 to 13.1) | − 2.1 (− 9.1 to 4.9) |
Diabetes mellitus | 10.7 (1.3 to 20.0)* | 3.8 (− 4.6 to 12.2) |
Smoking | 0.0 (− 6.9 to 6.9) | − 0.1 (− 6.2 to 6.0) |
Subtype CE (ref) | 0 (reference) | 0 (reference) |
LVD | 7.7 (− 7.9 to 23.3) | − 1.4 (− 15.0 to 12.2) |
CAD | − 9.0 (− 24.8 to 6.8) | − 2.3 (− 15.8 to 11.2) |
SAO | 8.8 (− 5.2 to 22.9) | 1.5 (− 10.6 to 13.6) |
Other determined | 10.4 (− 9.9 to 30.7) | 14.1 (− 3.3 to 31.5) |
Cryptogenic | 0.9 (− 12.2 to 14.0) | 1.4 (− 9.8 to 12.6) |
Undetermined | 8.5 (− 7.9 to 24.9) | 2.8 (− 11.3 to 16.9) |
Estimated R2 | ≤ 21% | 38% |